Paper4127616
Cytotoxic immune cells with specificity for defined soluble antigens. II. Chasing the killing cells.
Golstein P and 3 others. Cell Immunol, 1973. Cited by 32 papers, by iCite.
Cite this record
ConductScience Library. Cytotoxic immune cells with specificity for defined soluble antigens. II. Chasing the killing cells. Papers, record 4127616. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4127616
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Cytotoxic immune cells with specificity for defined soluble antigens. II. Chasing the killing cells.
- PubMed
Topics25
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibody Specificity | Major topic |
| Antigens | Major topic |
| T-Lymphocytes | Major topic |
| Absorption | |
| Animals | |
| Antilymphocyte Serum | |
| B-Lymphocytes | |
| Cell Adhesion | |
| Cell Separation | |
| Cells, Cultured | |
| Chickens | |
| Complement System Proteins | |
| Cytotoxicity Tests, Immunologic | |
| Dinitrophenols | |
| Erythrocytes | |
| Immunization | |
| Lymph Nodes | |
| Lymphocytes | |
| Macrophages | |
| Mast-Cell Sarcoma | |
| Mice | |
| Ovalbumin | |
| Serum Albumin | |
| Solubility | |
| gamma-Globulins |
Source PubMed
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 6553509 | Antibody-dependent cellular cytotoxicity-mediated serotherapy against murine neuroblastoma. II. In vitro and in vivo treatment using effector cells from normal and X-irradiated humans. | Cancer Immunol Immunother | 1983 | https://conductscience.org/library/papers/6553509 | PubMed |
| 4591177 | Lymphocyte proliferation in vitro induced by hapten autologous protein conjugates. I. A study on the class of lymphocytes responding in vitro and on the nature and specificity of their receptors. | J Exp Med | 1974 | https://conductscience.org/library/papers/4591177 | PubMed |
| 4547657 | A new sensitive assay for antibody against cell surface antigens based on inhibition of cell-dependent antibody-mediated cytotoxicity. I. Specificity and sensitivity. | J Exp Med | 1974 | https://conductscience.org/library/papers/4547657 | PubMed |
| 1254320 | Cell-mediated cytotoxicity. Characterization of the effector cells. | Immunology | 1976 | https://conductscience.org/library/papers/1254320 | PubMed |
| 1058493 | Lysis of leukemia cells by spleen cells of normal mice. | Proc Natl Acad Sci U S A | 1975 | https://conductscience.org/library/papers/1058493 | PubMed |
| 590999 | Apparent direct cellular cytotoxicity mediated via cytophilic antibody. Multiple Fc receptor bearing effector cell populations mediating cytophilic antibody induced cytotoxicity. | Immunology | 1977 | https://conductscience.org/library/papers/590999 | PubMed |
| 66114 | Antigen specific lymphocyte activity in vitro by peripheral blood leucocytes from Mantoux positive and negative human beings. I. Comparison of quantitative and qualitative differences in the PPD-specific lymphoproliferative response of lymphocytes from the two kinds of donors. | Clin Exp Immunol | 1977 | https://conductscience.org/library/papers/66114 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4127616
GET https://conductscience.org/api/papers/v1/4127616/authors